Teva expects sales injection from U.S. EpiPen market

Россия Новости Новости

Teva expects sales injection from U.S. EpiPen market
Россия Последние новости,Россия Последние новости

Teva Pharmaceutical Industries expects its generic version of Mylan's EpiPe...

  • 📰 Reuters
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

Reuters /  🏆 2. in RU
 

We need insulin to drop

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Teva expects about 25 percent of EpiPen market by year-endTeva expects about 25 percent of EpiPen market by year-endTeva Pharmaceutical Industries expects its generic version of Mylan's EpiPe...
Прочитайте больше »

Stocks making the biggest moves midday: Teva Pharmaceuticals, Hilton, Groupon & moreStocks making the biggest moves midday: Teva Pharmaceuticals, Hilton, Groupon & moreThese are the stocks posting the largest moves midday Wednesday.
Прочитайте больше »

Teva stock tumbles premarket as earnings and guidance fall short of estimatesTeva stock tumbles premarket as earnings and guidance fall short of estimatesHo ho I'm dead
Прочитайте больше »

Teva expects about 25 percent of EpiPen market by year-endTeva expects about 25 percent of EpiPen market by year-endTeva Pharmaceutical Industries expects its generic version of Mylan's EpiPe...
Прочитайте больше »

A US-China trade deal may not be the catalyst the market is expectingA US-China trade deal may not be the catalyst the market is expectingMarket strategists and policymakers are putting too much emphasis on a trade deal between the United States and China, and it's quite likely that whatever is agreed will disappoint. So it's going even higher? Sweet! Huge pop coming Tariffs make the dollar stronger and more jobs in America The redundancy in trading higher on the same headline is exhausting and manipulative. Real journalism please.
Прочитайте больше »



Render Time: 2025-01-14 09:39:00